ArticleAdvanced pharmaceutical bulletin2024

Cell Therapy Using Anti-NKG2A Pretreated Natural Killer Cells in Patients with Hepatocellular Carcinoma.

Shirin Tavakoli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.